相似文献
1
Reference group choice and antibiotic resistance outcomes.
Emerg Infect Dis. 2004 Jun;10(6):1125-8. doi: 10.3201/eid1006.020665.
2
Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Ann Pharmacother. 2008 Mar;42(3):317-26. doi: 10.1345/aph.1K501. Epub 2008 Feb 19.
3
Risk of acquiring antibiotic-resistant bacteria from prior room occupants.
Arch Intern Med. 2006 Oct 9;166(18):1945-51. doi: 10.1001/archinte.166.18.1945.
4
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i17-28. doi: 10.1093/jac/dkn250.
5
6
Antimicrobial resistance in gram-positive bacteria.
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S11-9; discussion S64-73. doi: 10.1016/j.ajic.2006.05.220.
7
[Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci].
Nihon Rinsho. 2002 Nov;60(11):2144-9.
8
Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Am J Infect Control. 2007 Mar;35(2):73-85. doi: 10.1016/j.ajic.2007.01.001.
9
Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Ann Pharmacother. 2004 Sep;38(9):1377-82. doi: 10.1345/aph.1E028. Epub 2004 Jul 20.
10
The prevalence of resistant bacterial colonization in chronic hemodialysis patients.
Am J Nephrol. 2007;27(4):352-9. doi: 10.1159/000103383. Epub 2007 May 26.
引用本文的文献
1
Trends in the Prevalence of Antimicrobial Resistance in Escherichia coli Isolated from Outpatient Urine Cultures in French Amazonia.
Am J Trop Med Hyg. 2024 Jun 25;111(2):287-296. doi: 10.4269/ajtmh.23-0887. Print 2024 Aug 7.
2
Antimicrobial Susceptibility of Community-Acquired Urine Bacterial Isolates in French Amazonia.
Am J Trop Med Hyg. 2023 Apr 3;108(5):927-935. doi: 10.4269/ajtmh.22-0242. Print 2023 May 3.
3
Eleven-Year surveillance of methicillin-resistant infections at an Academic Health Centre.
J Prev Med Hyg. 2022 Apr 26;63(1):E132-E138. doi: 10.15167/2421-4248/jpmh2022.63.1.2387. eCollection 2022 Mar.
4
A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
Front Public Health. 2022 Mar 17;10:853757. doi: 10.3389/fpubh.2022.853757. eCollection 2022.
5
Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Am J Trop Med Hyg. 2022 Jan 10;106(2):525-531. doi: 10.4269/ajtmh.20-1436.
6
Critical care medicine in the French Territories in the Americas: Current situation and prospects.
Rev Panam Salud Publica. 2021 Apr 28;45:e46. doi: 10.26633/RPSP.2021.46. eCollection 2021.
7
Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis.
Antibiotics (Basel). 2020 Feb 23;9(2):96. doi: 10.3390/antibiotics9020096.
8
IS-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Clinical Isolate.
Front Microbiol. 2019 Aug 14;10:1882. doi: 10.3389/fmicb.2019.01882. eCollection 2019.
9
Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016.
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62. doi: 10.1093/ofid/ofy344. eCollection 2019 Mar.
10
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Antimicrob Resist Infect Control. 2018 Nov 14;7:133. doi: 10.1186/s13756-018-0419-9. eCollection 2018.
本文引用的文献
1
The impact of antimicrobial resistance on health and economic outcomes.
Clin Infect Dis. 2003 Jun 1;36(11):1433-7. doi: 10.1086/375081. Epub 2003 May 16.
2
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.
Clin Infect Dis. 2003 Mar 1;36(5):592-8. doi: 10.1086/367653. Epub 2003 Feb 7.
3
Health and economic outcomes of vancomycin-resistant enterococci.
Arch Intern Med. 2002 Oct 28;162(19):2223-8. doi: 10.1001/archinte.162.19.2223.
4
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Emerg Infect Dis. 2002 Aug;8(8):802-7. doi: 10.3201/eid0808.010418.
5
Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium.
Emerg Infect Dis. 2002 May;8(5):490-5. doi: 10.3201/eid0805.010267.
6
Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Clin Infect Dis. 2002 Apr 1;34(7):922-9. doi: 10.1086/339211. Epub 2002 Mar 4.
7
Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases.
Am J Respir Crit Care Med. 2002 Mar 1;165(5):713-7. doi: 10.1164/ajrccm.165.5.2105110.
8
Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes.
Pediatr Infect Dis J. 2001 Sep;20(9):837-43. doi: 10.1097/00006454-200109000-00003.
9
Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains.
Infection. 2001 Oct;29(5):245-50. doi: 10.1007/s15010-001-1092-z.
10
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42. doi: 10.1086/501931.
Zotero 插件